Detection of factor V Leiden and prothrombin gene mutations in patients who died with thrombotic events: A retrospective allele-specific multiplex polymerase chain reaction study

Archives of Pathology and Laboratory Medicine

Volumn 126, Issue 10, 2002, Pages 1193-1196

  Ranguelov, Rostislav D ^a   Rosenthal, Nancy ^a   Bromley, Christine ^a   Vasef, Mohammad A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ALLELE; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FAMILY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INCIDENCE; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PROPHYLAXIS; RISK FACTOR; SCREENING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DNA; DNA PRIMERS; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; IOWA; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTHROMBIN; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 0036826526     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
2. Hillarp A, Zoller B, Dahlback B. Activated protein C resistance as a basis for venous thrombosis. Am J Med. 1996;101:534-540.
3. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med. 1997;127:895-903.
4. Dahlback B, Hillarp A, Rosen S, Zoller B. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis. Ann Hematol. 1996;72:166-176.
5. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.
6. Makris M, Preston FE, Beauchamp NJ, et al. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost. 1997;78:1426-1429.
7. De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999;341:801-806.
8. Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374-380.
9. Bokarewa MI, Bremme K, Blomback M. Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol. 1996;92:473-478.
10. Hallak M, Senderowicz J, Cassel A, et al. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Am J Obstet Gynecol. 1997;176:889-893.
11. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood. 1997;90:1747-1750.
12. Doggen CJM, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation. 1998;97:1037-1041.
13. Longstreth WT, Rosendaal FR, Siscovick DS, et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke. 1998;29:577-580.
14. Mansourati J, Da Costa A, Munier S, et al. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost. 2000;83:822-825.
15. Van de Water NS, French JK, Lund M, Hyde TA, White HD, Browett PJ. Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol. 2000;36:717-722.
16. Inbal A, Freimark D, Modan B, et al. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood. 1999;93:2186-2190.
17. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999-1004.
18. Gowda MS, Zucker ML, Vacek JL, et al. Incidence of factor V Leiden in patients with acute myocardial infarction. J Thromb Thrombolysis. 2000;9:43-45.
19. Redondo M, Watzke HH, Stucki B, et al. Coagulation factors II, V, VII, and X, prothrombin gene 20210G → A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. Arterioscler Thromb Vasc Biol. 1999;19:1020-1025.
20. Gorman TE, Arcot AN, Baker P, Prior TW, Brandt JT. Prevalence of the factor V Leiden mutation among autopsy patients with pulmonary thromboembolic disease using an improved method for factor V Leiden detection. Am J Clin Pathol. 1999; 111:413-417.
21. Kohlmeier RE, Cho CG, Bux RC, et al. Prothrombin gene mutation uncommon in pulmonary embolism. South Med J. 2000;93:1073-1077.
22. Ripoll L, Paulin D, Thomas S, Drouet LO. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost. 1997;78:960-961.
23. Hezard N, Cornillet-Lefebvre P, Gillot L, Potron G, Nguyen P. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G → A 20210 prothrombin gene and C → T 677 MTHFR gene mutations. Thromb Haemost. 1998;79:1054-1055.
24. Lane DA, Mannucci PM, Bauer KA, et al, Inherited thrombophilia: part 1. Thromb Haemost. 1996;76:651-662.
25. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
26. Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. Br J Haematol. 1997;98:907-909.
27. Van der Meer FJM, Koster T, Vanderbroucke JP, Briet E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost. 1997;78:631-635.
28. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999; 353:1167-1173.
29. Lutz CT, Foster PA, Noll WW, et al. Multicenter evaluation of PCR methods for the detection of factor V Leiden (R506Q) genotypes. Clin Chem. 1998;44: 1356-1358.
30. Dunn ST, Trong S. Evaluation of role of factor V Leiden mutation in fatal pulmonary thromboembolism. Thromb Res. 1998;91:7-14.